Interferon-gamma release in sympathetically denervated rat submaxillary lymph nodes

被引:10
作者
Castrillón, PO
Cardinali, DP
Arce, A
Cutrera, RA
Esquifino, AI
机构
[1] Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol 3, Madrid, Spain
关键词
interferon-gamma release; mitogenic responses; submaxillary lymph nodes; superior cervical ganglion; sympathetic nerves; norepinephrine;
D O I
10.1159/000054280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the regulation of interferon (IFN)-gamma release by cells derived from submaxillary lymph nodes of rats subjected to an acute or chronic superior cervical ganglionectomy (SCGx). Methods: A unilateral SCGx and a contralateral sham operation were performed. Twenty hours or 7 days later cells from submaxillary lymph nodes were incubated for 24 h without any additional treatment (experiment 1), after adding lipopolysaccharide or concanavalin A (experiment 2) or after adding norepinephrine (NE, 10(-8) M; experiment 3). IFN-gamma concentration in the culture media was measured by ELISA. Results: Compared to controls, cells obtained from lymph nodes at a time of degeneration of sympathetic nerve terminals released more IFN-gamma, whereas those derived from chronically SCGx lymph nodes released less IFN-gamma. Stimulation of IFN-gamma release by mitogens was detectable in the innervated or acutely denervated lymph nodes, but not in chronically denervated lymph nodes. When the effect of 10(-8) M NE on IFN-gamma release was tested, the neurotransmitter augmented cytokine release in cells prepared from chronically denervated lymph nodes only. Conclusion: The microenvironment provided by local sympathetic nerves is essential to enable an appropriate IFN-gamma release by submaxillary lymph node cells to occur. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 26 条
[1]   Dopamine β-hydroxylase deficiency impairs cellular immunity [J].
Alaniz, RC ;
Thomas, SA ;
Perez-Melgosa, M ;
Mueller, K ;
Farr, AG ;
Palmiter, RD ;
Wilson, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2274-2278
[2]  
ALITO AE, 1987, ACTA PHYSIOL PHARM L, V37, P305
[3]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[4]   Immunomodulatory properties of interferon-γ -: An update [J].
Billiau, A ;
Heremans, H ;
Vermeire, K ;
Matthys, P .
MOLECULAR MECHANISMS OF FEVER, 1998, 856 :22-32
[5]   Central nervous system activation following peripheral chemical sympathectomy: Implications for neural-immune interactions [J].
Callahan, TA ;
Moynihan, JA ;
Piekut, DT .
BRAIN BEHAVIOR AND IMMUNITY, 1998, 12 (03) :230-241
[6]  
Cardinali D. P., 1998, BIOMED REV, V9, P47
[7]  
CARDINALI DP, 1991, FRONT NEUROENDOCRIN, V12, P278
[8]  
Castrillón PO, 1998, BIOL SIGNAL RECEPT, V7, P25
[9]  
Cole SW, 1998, J IMMUNOL, V161, P610
[10]  
EMMELIN N, 1972, REV PHYSL BIOCH EXP, V66, P148